Cardiac Biomarkers Testing Market Size with Focus on Emerging Technologies, Top Countries Data, Top Key Players Update, and Forecast 2028 with COVID-19 Impact Analysis

(Heraldkeepers via Comtex)

Report Ocean publicize new report on the cardiac biomarkers testing market. The cardiac biomarkers testing market report contains numerous information about factors, such as market restraints, drivers, and opportunities. In addition, the report provides an in-depth review of industry developments and trends in the market that are influencing the cardiac biomarkers testing market growth. Additionally, the database analyzes and estimates the cardiac biomarkers testing market both globally and regionally.

According to this new report, the global cardiac biomarkers testing market is estimated to be valued at US$ 5.7 billion in the year 2028, growing at a CAGR of 8.5% in the period 2020 to 2028. Growth of the market is driven by the prevalence of cardiovascular cases, increasing geriatric population, higher precision and its non-invasiveness.

Request To Download Sample of This Strategic [email protected]

Cardiac biomarkers testing is used for diagnosis of various cardiovascular diseases such as cardiac ischemia, myocardial infarction, congestive heart failure, and acute coronary syndrome. Cardiac Biomarkers are basically protein molecules that are released into the bloodstream after heart damage or heart-stress. Hence measuring biomarkers usually serves as an important early step in diagnosing a heart attack.

The use of cardiac biomarkers in combination are widely applied in clinical diagnosis, risk stratification, and management of patients with or without cardiovascular diseases. One of the potent cardiac biomarker combinations is that of cTn and BNP which is quantitative markers of cardiac damage.

Parameter Description

Base year: 2016

Forecast period: 2020 - 2028

Market sizing: Revenue in US$ Billions & CAGR for the period 2016 to 2028

Country coverage: The US, The UK, Germany, Japan & China

Vendor scope: Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Becton, Dickinson and Company, Bio-Rad Laboratories & BioMerieux

Report coverage: Revenue forecast, market share analysis, company analysis, competitive landscape, market growth drivers, market restraints, market trends and company profiles

Request To Download Sample of This Strategic [email protected]

COVID-19 Impact

The COVID-19 pandemic in 2019 engulfed the world. It caused a worldwide halt. The entire global economy was affected. In addition, many people have also lost their lives. Around 252,297,094 cases and 5,091,465 deaths have been reported worldwide so far for COVID-19. The pandemic spread to almost every country in the world. In most industries, the pandemic resulted in some form of loss. As a result of the pandemic, the cardiac biomarkers testing market also experienced a slowdown. Statista estimates that the cardiac biomarkers testing market total worldwide revenue stood at approximately US$ 3.94 trillion in 2019. In 2014, the cardiac biomarkers testing market generated revenues of US$ 5.4 trillion at a record high.

The degree of competition among prominent global companies has been developed by analyzing several leading competitors operating globally. In addition, specialist analysts examine various aspects of the cardiac biomarkers testing market, including market competition, market share, the most recent advancements in the industry, innovative product launches, partnerships, mergers, and acquisitions by leading companies.

Get a Sample PDF copy of the [email protected]

Segments Covered

The report provides revenue forecasts for global, regional, and country levels. It also provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. For the purpose of research, the publisher has segmented global cardiac biomarkers testing market report on the basis of type, applications, testing location and geography.

Biomarkers Testing Type Outlook

Creatine Kinase (CK-MB)


Ischemia Modified Albumin (IMA)


Natriuretic Peptides

Biomarkers Testing Application Outlook

Acute Coronary Syndrome

Myocardial Infarction

Congestive Heart Failure


Biomarkers Testing Location Outlook

POC Testing

Laboratory Testing

Country Outlook, Revenue

The US

The UK





Vendors Outlook

Roche Diagnostics

Abbott Laboratories

Siemens Healthcare

Becton, Dickinson, and Company

Bio-Rad Laboratories


Target Audience

Drug Manufacturers

Chemical Suppliers

End Users

Research Professionals

Healthcare Consultancies

Regulatory Bodies

Get a Sample PDF copy of the [email protected]

Key questions answered in the cardiac biomarkers testing market report are:

How does a global company acquire markets?

What are its core strategies and policies?

What factors will influence the cardiac biomarkers testing market market over the forecast period?

What are the factors driving and restraining the market for cardiac biomarkers testing market?

What are the leading competitors in the global market?

Which region is growing at a higher pace in the global market?

Access full Report Description, TOC, Table of Figure, Chart, etc:

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today's competitive environment. Report Ocean is a 'one-stop solution' for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:

Report Ocean:

Email: [email protected]

Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 - UNITED STATES

Tel: +1 888 212 3539 (US - TOLL FREE)


Source - HeraldKeeper
Note: The Heraldkeeper News Department was not involved in the creation of this content.

If you have any problem with this press release? Contact the source provider, you can contact them here. comtex tracking